IRWD is trading at 5.8% up now at $4.36, extending gains that began after the company issued strong 2026 financial guidance highlighting significant growth in LINZESS sales and adjusted EBITDA. The stock had previously surged over 30% on that guidance and is now moving higher in a generally positive U.S. market, suggesting ongoing investor optimism around the updated outlook.